Mouradov and co-worker analyzed the disease free survival (DFS) in 822 patients with CRC stage II/III and correlated this data with MSI, CIN, and a number of molecular biomarkers, including PIK3CA (18). The gene discussed is PIK3CA; the disease is cervical squamous intraepithelial neoplasia.